2022. The evaluation of Paclitaxel effects on the Caco-2 cell line of colon cancer patients. Journal of Pharmaceutical Negative Results. (Sep. 2022), 459–463. DOI:https://doi.org/10.47750/pnr.2022.13.S01.56.